General Information of Drug Transporter (DT)
DT ID	DTD0020 Transporter Info
Gene Name	SLC10A2
Protein Name	Apical sodium-dependent bile acid transporter
Gene ID	6555
UniProt ID	Q12908
Genetic Polymorphisms of DT (GPD)
Genetic Polymorphism	rs2301159
Site of GPD	chr13:103045378 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	A=0.2704/1354 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Docetaxel	Drug Info	Prostatic Neoplasm	Correlated with the increased drug toxicity risk in patients (compare with allele G)		[ 1]
Thalidomide	Drug Info	Prostatic Neoplasm	Correlated with the increased drug toxicity risk in patients (compare with allele G)		[ 1]
Genetic Polymorphism	rs7319981
Site of GPD	chr13:103071372 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	A=0.3790/1898 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            3 Drugs in Total
Daunorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele G)		[ 2]
Doxorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele G)		[ 2]
Anthracyclines	N.A.	Neoplasm	Correlated with the decreased likelihood of cardiotoxicity in patients (compare with allele C)		[ 3]
Genetic Polymorphism	rs9514091
Site of GPD	chr13:103061904 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	A=0.2346/1175 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            3 Drugs in Total
Daunorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele G)		[ 2]
Doxorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele G)		[ 2]
Anthracyclines	N.A.	Neoplasm	Correlated with the decreased likelihood of cardiotoxicity in patients (compare with allele C)		[ 3]
References
1	A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. Pharmacogenomics J. 2010 Jun;10(3):191-9.
2	Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer. 2013 Aug;60(8):1375-81.
3	Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol. 2012 May 1;30(13):1422-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.